Accelerating the Development of Curative Medicines with Functional Immune Profiling

Learn how to accelerate predictive insights into translational research and the development of novel immune therapies with IsoPlexis’ Functional Single-Cell Proteomics.

Your data is secure

We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from IsoPlexis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this we discuss:

Analysis of dynamic immune processes fills gaps in understanding of severe COVID-19 pathogenesis
Identifying key drivers of transplant rejection with single-cell immune profiling
Resolving challenges of oncolytic immunotherapy delivery to disrupt the tumor microenvironment with functional single-cell proteomics
IsoPlexis’ immune profiling accelerates pre-clinical animal models and development timelines
Generate unique in vivo insights with highly multiplexed immune profiling
A Deeper Look

More about this

Accelerating the Development of Curative Medicines

Functional Single-cell Proteomics is critical to fully characterize cellular function, how it pertains to patient outcomes such as anti-tumor response or disease progression, and to accelerate predictive insights into translational research and the development of novel immune therapies.

Download this eBook to learn how IsoPlexis’ Functional Single-cell Proteomics works and to review recent studies in which our technology delivered key omic insights with the potential to accelerate curative medicines.

awards-bar-3-wide-color-right
awards-bar-4-wide-color-left
Get the